All News
Filter News
Found 808,679 articles
-
Targeted Genetics Corporation to Host Conference Call and Webcast Discussion of Annual Shareholders Meeting on February 18, 2011
2/16/2011
-
Discovery Laboratories Prices $23.5 Million Public Offering of Common Stock and Warrants
2/16/2011
-
Discovery Laboratories Announces Proposed Public Offering of Common Stock and Warrants
2/16/2011
-
Urologix Announces Grant of 180-Day Extension to Regain Compliance With NASDAQ Minimum Bid Price Requirement
2/16/2011
-
Bioanalytical Technologies Introduces Enhanced Drug Discovery Services
2/16/2011
-
Daxor Corporation Announces Launch of Multicenter Research Study to Investigate Whether Direct Blood Volume Measurement Leads to Improved Outcomes in Heart Failure Patients
2/16/2011
-
BG Medicine President and Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell
2/16/2011
-
Pan Globus: Middle East Could be Key to US Medical Device Success
2/16/2011
-
SinoFresh Healthcare Announces Execution on New Strategic Plan
2/16/2011
-
The Shanghai Municipal Health Bureau Bars 3 Medical Device Firms for Bribery
2/16/2011
-
Alliance Medical Products Receives Good Manufacturing Practice (GMP) Certification
2/16/2011
-
Bacterin International, Inc. to Announce Launch of OsteoSponge(R)SC at American Academy of Orthopedic Surgeons 2011 Annual Meeting February 15-19
2/16/2011
-
Advocate Health Care Selects Digisonics for Structured Reporting and Image Management
2/16/2011
-
Cerno Bioscience Introduces MassWorks AutoID for Fully Automated Quadrupole MS Formula Determination
2/16/2011
-
Ablynx Will Announce Full Year Results for 2010 With Webcast
2/16/2011
-
Adolor Corporation to Host Investor Conference Call to Report Year-End 2010 Results
2/16/2011
-
Alphatec Spine to Hold 4Q 2010 Financial Results Investor Call
2/16/2011
-
Adolor Corporation to Host Investor Conference Call to Report Year-End 2010 Results
2/16/2011
-
Cell Therapeutics, Inc. Reports Fourth Quarter Total Net Operating Expenses Declined 38% in 2010 Compared to 2009, Balance Sheet Strengthened With Recent $25 million Financing
2/16/2011
-
Genzyme Corporation Reports Financial Results for Fourth Quarter of 2010 and Full Year
2/16/2011